Life Sciences Entrepreneur Bootcamp
Transcript of Life Sciences Entrepreneur Bootcamp
1
Entrepreneurs Bootcamp
October 7, 2015
Life Sciences
East Meets West Coast:
Structure Your Company So
Everyone Wins!
2
Schedule
9:00 a.m.
9:30 a.m.
9:35 a.m.
10:00 a.m.
10:45 a.m.
11:00 a.m.
11:45 a.m.
12:30 p.m.
1:30 p.m.
2:15 p.m.
3:00 p.m.
3:45 p.m.
Registration & Networking
Welcome Remarks
Overview/Life Sciences Trends
Forming/Organizing the Start-up Entity
Break
Business Plans & Fundraising
Tales From The Trenches I
Networking Lunch
Valuation & Term Sheets
Liquidity & Exits
Tales From The Trenches II
Q&A/Adjourn/Networking
3
OVERVIEW
4 4
• Premier provider of value-added legal services to growth business
enterprises worldwide, as well as the public and private capital markets that
finance them
• Represent multi-billion dollar global enterprises as well as venture-backed
start-up companies
• Our track record:
– Represent more companies that receive venture financing than any other
law firm
– Advise more U.S. companies on their initial public offerings than any other
law firm
– Represent more technology companies in mergers and acquisitions than
any other U.S. law firm
– Advise more than 300 public and 3,000 private enterprises on issues of
corporate law, securities, and corporate governance
5
Our Business Model
6
On the Forefront of the Life Sciences Industry
Note: some clients may have merged or been acquired
Represent more than 500 life sciences clients, including:
7
7
7
9
9
9
15
26
47
62
Mintz Levin
DLA Piper
Latham &…
Fenwick & West
WilmerHale
Gunderson…
Goodwin…
Cooley
WSGR
*Source: Dow Jones VentureSource market share based on firms with 7 or more financings in 2014
• Founded in 1961 with over 650
attorneys located across the globe
• Actively represent more than 3,000
private companies
• Deep relationships in the venture
capital community
• Incorporate thousands of successful
businesses
• Provide value-added resources:
• Entrepreneurs College
• Entrepreneur’s Report
• Life Sciences Report
• Online Term Sheet Generator
• Bootcamps
• Office Hours
WSGR represents more life sciences companies that
receive venture financing than any other U.S. law firm*
Entrepreneur & Private Company Practice
8
Select Life Sciences Venture Capital Clients
8
9
VC Overview: The Good news
Commitments to Venture Capital
Funds (All Industries) (Based on multiple closings)
Source: Dow Jones VentureSource
VC Fundraising 1H’ 2015 vs 2007
10
Deal Flow
and Equity
into Venture-
Backed
Healthcare
Companies
Source: Dow Jones VentureSource
VC Overview: The Good News (cont.)
Healthcare Investment Steady in Q2 2015
11
VC Overview: The Bad News
The Number of Healthcare Deals steady in Q2 2015
Number of healthcare*
mega deals done by
year
(Amount raised +$100M)
*Source: Pitchbook **Source: Dow Jones VentureSource
12
VC Overview: The Bad News (cont.)
Since 2008 we’ve seen a consolidation of VC dollars in
precious few large, branded funds
The number of VC’s doing 3-5 deals
has been trending down
Source: Thompson One, Dow Jones Venture Source
The Concentration of VC $
13
Early Stage Financings
• Early stage companies are increasingly using
nontraditional methods of financing
– Non-equity crowdfunding sites
– Series seed financing
– Convertible equity
– Government grants and tax incentives
• JOBS Act authorized the SEC to promulgate rules
for equity crowdfunding, but the SEC has yet to
approve regulations
14
Angels & Incubators Filling In The Gaps
• Seed stage activity has experienced a paradigm shift as well.
Reduced costs to start a technology company have led to the
rise of new players such as “super angels” and incubators that
have filled gaps left by departing VCs
Seed investing moderated some but
remains at historically high levels
Participation by Angels &
Incubators is also at an all-
time high
Source: Thompson One, EY Venture Insights
15
The Median Amount Raised in Pre-Series A
Bridge Loans Doubled from 2013 to 2014
Median Amount Raised – Bridge Loans
16
VC Overview: Healthcare Investment Allocation
Healthcare Services Investment Shrinks in 2Q’ 2015
Source: Dow Jones VentureSource
17
Seed Stage Valuation Trends
• In 2011, the median seed stage pre-money valuation ($4.0M)
was the highest it had been post bubble. Since 2011, seed
stage valuations have declined—the median seed stage pre-
money valuation of $2.5M in 2013 represented a 30% decline
over 2012
• There is reason to remain optimistic. In 2014, as fundraising
levels have started to rise, financing rounds have increased in
size, and competition for deals has grown, we are beginning to
see an uptick
Source: Thompson One
18
Early Stage Pre-Money Valuations Up in 2014
Median Pre-Money Valuation
19
Valuation Trends for 2014
No. of High Pre-Money Valuations by Year $200M and above (U.S. deals only)
Pre-Money Valuations The number of high pre-money valuations
($200 million or more) jumped from 31 in 2013
to 48 in 2014. The number was 17 in 2010.
Valuations 48 WSGR deals had
valuations of $200M or
more in 2014.
Amounts Raised Median amounts raised in 2014
were the highest WSGR has
recorded since 2010.
20
What this means to Start-ups
• Recognize the venture model has undergone a paradigm shift:
– Diversity of sources of funds
– Disaggregated and disparate angels and super angels
– Emergence of incubators and accelerators
– VC funds adopting seed stage strategies
– More venture capital concentrated into few funds
• Valuation is as much “art” as it is “science” and is a function of deal-
specific and industry-specific factors as well as a function of the
venture economic model
• More than ever, fundraising is a “full contact” sport and will require
perseverance and a dedicated and sustained “team” effort
– Build a team of advisors that not only bring expertise and
credibility, but also bring a broad network of potential funding
contacts
21
FORMING & ORGANIZING THE
START-UP ENTITY
22
Essentials of Start-up Law
• Forming and Organizing the Start-up
• Founders Stock
• Equity Incentives
23
Choosing the Form of Business Entity
• Current status
– Partnership
– Sole proprietorship
• Why Limited Liability?
• Two common organizations
– Limited liability company
– Corporation
24
Limited Liability Company
• Limited liability corporation (LLC)
– LLC members can operate as managers; all owners
have limited liability (i.e., only the amount of their
investment)
– No entity-level tax – taxes pass through to LLC
members
– Ownership interests of the “members” are defined
and established in the LLC operating agreement
Why doesn’t an LLC work for a VC-backed start-up?
25
Corporation
• Attributes of a C corporation
– Corporate governance
Stockholders elect board of directors
Board appoints officers, oversees strategic direction
Officers manage day to day affairs of the company
– No pass through of tax benefits
C corporation is taxed as a separate legal entity (unlike the LLC and
the S Corporation).
– VCs can invest in it; employees can understand stock
incentives
26
Corporation: Advantages
• Perpetual life
• Separation of Ownership from Management
• Fringe Benefits (Incentive Stock Options)
• Familiarity
• Limited Liability
26
27
Corporation: Disadvantages
• Separate Tax Payer – the “Double Tax”
– Subchapter “S” Corporations
– Offshore Corporations
Cost
27
28 28
Shareholders
Optionees
Investors Employees Others
Board of
Directors
CEO
Other Employees
VP VP VP VP VP
29
Creating & Organizing the Corporation
• Jurisdiction of Incorporation
• Directors
• Charter and Bylaws
• Stock Issuance
29
30
Where to Incorporate
• Delaware or Maryland?
– Cost
– Filing services
– Beneficial corporate law
– IPO objectives and
reincorporation
30
31
Corporation
• S corporation has board members/shareholders,
etc.; but—
– Tax benefits and losses passed through to the individual shareholders
(i.e., a single level of taxation)
– Early stage start-ups will sometimes take advantage of “S Corporation”
status: losses get passed through to the owners
• Requirements for S corporation status: – no more than 100 shareholders
– all individuals (no corporation) (family trusts are OK in general)
– no “foreign” shareholders
– only one class of stock (i.e., no preferred stock)
• Simple conversion to C corporation
Why doesn’t an S corporation structure work for a VC-
backed start-up?
31
32
Limited Liability Can be Lost
• The Corporate Veil Can Be Pierced
– Failure to Observe Corporate Formalities
– Commingling of Assets and Affairs
– Under Capitalization
– Deception
• Guarantees
32
33
Start-up Documents: 4 Buckets
• Incorporation documents
• Founder documents
• Employee documents
• Basic third party agreements
34
Incorporation Documents
• Certificate of Incorporation
• By-laws
• Organizational minutes and resolutions
– Establish Board
– Appoint Officers
– Issue stock
– Other Administrative matters
35
Faculty Founders
• When a company is formed, often the faculty
member does not leave his or her post
• Often, the faculty member serves as a consultant
and is on the Scientific Advisory Board
– Normally a limit on time (e.g., 20%)
• Company may put in place a Sponsored Research
Agreement with faculty member’s lab
• Faculty members need to check with the relevant
administrative departments to understand relevant
policies. Tech Transfer Office can help navigate.
36
Founder Documents: Founders’ Stock
• Typically purchased pursuant to a Restricted Stock
Purchase Agreement
• Founders’ stock: the first step in capitalizing the
Start-up
– Nearly always common stock
– Typically issued in exchange for IP, business plan or
nominal cash
– Usually issued at low value
37
Founder Documents: Vesting – Why put in place?
• Solo founder
• Multiple founders
• Financings
38
Founder Documents: Vesting – What is it? Why Put
it in Place? • Concept that recipient does not “own” all shares when issued
• Vesting also can, and typically does, apply to Options
– Mechanics depend on type of grant (Restricted Stock versus
Options)
• What are typical vesting provisions?
– Founders
– Employees
• Why put it place?
– One vs. Multiple Founders
– Financings
39
Founder Documents: Acceleration Terms of
Founders’ Stock • Termination of employment
– “Cause” and “Good reason”
• Change of control
• Single trigger vs. double trigger
• Also can apply to options
40
Founder Documents: Tax Considerations
• General Rule – Founders are taxed on FMV of
shares as they vest (i.e., as shares become “no
longer subject to forfeiture”)
• Exception
– File 83(b)!
– Choose to tax at grant
– File within 30 days
– No second chance!!
41
Employee Documents
• Offer letter
• Invention Assignment Agreement
• Options
– What is an Option?
– Option Plans
– Issuing Options
– Process for Granting Options
– ISOs & NSOs
– 409A
42
Employee Documents:
Options – What is an option?
• Right to buy Stock at a set price
• Typically granted to employees, board members,
advisors and consultants
• Issued through an “option plan”
43
Employee Documents:
Stock Plans • Equity incentive structures for directors, employees and
consultants are usually implemented through the adoption and
administration of a “stock plan” or “stock option plan” (these
are synonymous)
– A stock plan is a formal written document approved by the
board of directors and the shareholders. The stock plan
establishes a “reserve” of stock (i.e., authorized but
unissued shares that are set aside, or earmarked,
specifically for issuance under the stock plan)
– VC investors include the reserve in negotiating valuation.
They want to ensure that the reserve is established at an
adequate level to avoid post-financing dilution to their
negotiated equity stake in the company
44
Employee Documents: Options – Issuing
Options
• Every option grant/restricted stock grant has to be
approved by the board, and the board has to establish
the stock price (i.e., FMV)
– Result: Changes in stock price are determined at board
meetings, when the board approves option grants/stock grants
• How boards must price common stock in connection with
option grants/stock grants
– Objective is to price the common stock at or above fair market
value
– Section 409A of the Internal Revenue Code in many cases
requires pricing based on an independent valuation
45
Employee Documents: Options – Process for
Granting Options • Review Charters, Bylaws, Plan and Constituent
Documents
• Review Securities Laws (Note: MD requires filing)
• Corporate Approval
• Issuing the agreement and maintaining good records
• Clean-up is costly so better to get it right the first time!
46
Employee Documents: Options –
Nonstatutory Stock Options (NSOs)
• An NSO is any option that does not qualify as
an ISO
• No tax at grant
• At exercise, ordinary income = “spread”
• Subject to tax withholding (regardless of liquidity of
underlying shares); form W-2
• Sale – capital gain/loss – basis = purchase price + ordinary income recognized on exercise
– long-term capital gain/loss if held for > 1 year
47
Employee Documents: Options – Incentive
Stock Options (ISOs)
• An ISO is eligible for favorable tax treatment
• Key Concepts:
– No tax at grant
– No tax at exercise (purchase)
Unless alternative minimum tax (AMT) applies
– Sale or other disposition triggers income
– Tax consequences differ depending on whether
disposition is “qualifying” or “disqualifying”
48
Employee Documents: Options – ISOs
• Applicable Holding Periods
– 2 years from ISO grant AND
– 1 year from ISO exercise (purchase)
• Meeting BOTH of these holding periods results in a
QUALIFYING disposition
• Failure to meet EITHER of these holding periods
results in a DISQUALIFYING disposition
49
Employee Documents: Options –
Characteristics of ISOs
• ISOs must be granted pursuant to a written plan that:
– sets forth number of shares,
– states class of employees, and
– is approved by majority of S/Hs w/in 12 months of
Board Adoption.
50
Employee Documents: Options –
Characteristics of ISOs (cont.)
• Exercise price must be 100% of FMV on date of grant
(110% FMV for 10% S/Hs)
• Can only be granted to EMPLOYEES of company (or
parent or subsidiary)
• Maximum term of 10 years (5 yrs for 10% S/Hs)
• Must be exercised within 3 months of termination (12
months if disability)
51
Employee Documents:
Options – Section 409A
• Discount stock options are treated as a deferral of
compensation under Section 409A
• Stock options covering other than “service recipient
stock” provide for a deferral of compensation
– Only includes common stock (i.e., does not include
preferred stock)
– Options in subsidiary stock potentially problematic
52
Employee Documents:
Options – Section 409A (cont.)
• Tax at time of vesting, not date of exercise
• Potential interest penalty
• Employers have reporting and withholding
requirements
53
Third Party Documents
• Form NDA
• Consulting Agreement
• Licenses
54
Licensing: Steps for Success
Get Prepared
Get an Option /
Negotiate a Term Sheet
Create a Schedule
Use the University’s
Form
Make it Win-Win
55
Get Prepared (I)
• Understand what you want to license
– Patent rights/Know-how/software/other
• Evaluate the business opportunity
– The product
– Market size
– Existing players
– The technology fit
– Pricing/margins
– Investment requirements
56
Option/Letter of Intent (LOI)
• Objective: Obtain an exclusive right to negotiate a
license to the technology of interest for a defined
period
– Strategic decision: include key terms?
• Quid Pro Quo (usually there is one)
– Fee (usually nominal, if at all)
– Ongoing patent costs
57
Negotiate A Term Sheet
• Allows you to resolve the business issues first
• Avoids getting mired in the weeds
• Who prepares the first draft?
58
Key Points
Economic Terms
• Upfront
• Royalty
• Milestones
• Sublicensing
Revenue
• Patent Costs
• Equity
Non-Negotiable
• Indemnification
• Product Liability
• Retained Rights
• Right to Publish
• Use of Name
• Warranty
Non-Economic Terms
• Scope of IP (subject
matter, field of use)
• Exclusivity
• Retention of rights
and option to new IP
• Diligence
• Sublicensing
Restrictions
• Patent Prosecution
& Enforcement
• Assignment
59
Create a Schedule
• A schedule creates a useful time pressure and sets
expectations
• Be realistic
• If you want the other side to meet its schedule,
make sure to live by yours
60
Use the University’s Form
• Avoids need for extensive revision (saves time)
– Addresses University’s needs/concern
– Often specific language has been mandated
• You will get an opportunity
• Things that are generally required:
– Indemnification
– Insurance
– Diligence
• Things you won’t get:
– Ownership of university inventions
– Ability to block publication
– Extensive representations & warranties
61
Make It Win-Win
(It’s only the beginning)
• Communication is key
• The negotiation/agreement is only the beginning of
the relationship
• Keep perspective – it’s about creating a successful
company not getting a perfect agreement
62
Recent Example of a University License
• The Assets
• Patents claiming
compositions of small
molecules with early
indication of activity in CV
indications
• Data from cell and animal
studies
• The Terms
• $25K/year for 3 years and $10K/year thereafter
(creditable against royalties payable in same year)
• 2% equity (antidilution for 1st $4MM)
• 2% of <$500MM annual net sales
• 3% >$500MM – 1B annual net sales
• 4% >$1B annual net sales
• 50/50 stacking and combination reductions
• Milestones:
– $50K on initiation of Phase 1
– $100K on initiation of Phase 2
– $250K on initiation of Phase 3
– $250K on marketing approval
• Sublicensing revenue sharing
– 35% on sublicenses before first anniversary;
– 10% after first anniversary but before third
anniversary of agreement;
– 5% after third anniversary OR initiation of
clinical trial
• Reimburse for patent expenses
• Diligence with ability to purchase extensions
63
BREAK
64
BUSINESS PLANS &
FUNDRAISING
65
The Business Plan
• Purposes
– Convey to others (i.e., investors) what you (will) do
with their money
– Force yourself to figure out how you will do it
– Demonstrate to others (i.e., investors) that you really
understand the space and have thought about all the
challenges
66
The Business Plan
• Resources
– Other business plans
– IPO prospectuses
– Advisors
– Amazon
– But you have to write it yourself
67
The Business Plan
• Executive summary
– Elevator pitch
• PowerPoint business presentation
– Deeper consideration
• Extended long-form plan (optional)
– Detailed road map for business
• Financial and projections
– Include disclaimer!
68
Executive Summary
• 1-2 pages
• Easy to read and navigate
• Highlights:
– Team
– What do you do?
– What is the addressable market?
– What makes you different?
– How far along are you and what’s next?
• This just starts the dialogue – it’s not a Ph.D. thesis
69
PowerPoint Business Presentation
• No more words than necessary
• Don’t waste time on the obvious
• 10-15 slides
• Same substantive points as Exec Summary, but
now with 1-2 slides per point rather than 1-2
sentences
– Third party market data
– Revenue model
– Differentiators
– The team and key advisors (one slide)
70
Financials and Projections
• Income statement, Balance sheet, Cash flow statement
• How does funding accelerate growth?
• How long does the funding take you and how much more do
you need then?
• Don’t: “The market is $50B, but we are conservative,
assumed we’ll get merely 6% and cut that by 60%.”
• Everyone knows the projections won’t come true – it’s the
process and thinking that counts, and yes, it’s a test.
71
Back-Up Materials
• Market background
• IP background
• Risk assessment
• Competitive landscape
• References
• Potential industry/other experts
• Other diligence materials
72
Exercise for Working on Your Business Plan
• Identify your 4-5 top risks and uncertainties
– What can be done to reduce key risks pre-financing?
– What can be done to reduce key risks cost-
effectively post-financing?
• Identify your use of proceeds and how a cash
infusion may accelerate growth, timing, etc.
• Identify other elements beyond cash that you want
investors to bring to the table (i.e., partners,
additional management, strategic perspective, etc.).
73
Capitalization: Practical Tips
• #1 Get the founders’ stock arrangements right!
– Make sure the founders are ok with their allocation
– Establish vesting schedule although the VCs may
reverse it later
– “Buy/sell” arrangements are generally not necessary
• #2: Anticipate up to 50% dilution for first/second
rounds
– Set aside approximately 20% for future employees in
the early stage
74
Capitalization: Practical Tips
• #3: Establish an overall financing strategy
– Create an incentive matrix for all positions in the
organization
– Determine when you need to raise financing and
how much Establish milestones that demonstrate viability/progress
Expect 4-6 months process from beginning to receipt of
funds
75
Two Basic Approaches for Financing
• Equity
– Common stock
– Series A Preferred Stock
– “Seed” preferred stock
• Debt
– Bank loans
– Convertible promissory notes
76
Considerations in Structuring Financings for
Start-Ups • Three over-arching themes
– Protection of founders
– Incentivize investors
– Cost and speed
• Specific issues
– Amount being raised
– Identity of investors
– Terms (economic, governance, etc.)
77
Equity – Common Stock
• What is common stock?
• Straightforward way to raise equity
– Usually no rights or preferences
– No downside protection (i.e., liquidation preference) for
investors
• Valuation must be determined
– Most significant negotiating point
– Sets price for option grants
• No VC’s and usually only non-professional angel
investors will do it (best suited for friends and family
round)
78
Equity – Series A Preferred Stock
• What is preferred stock?
• Typically the most complicated way to raise equity
– Must establish separate rights, preferences and privileges
of preferred stock
– Extensive economic AND governance provisions
– Must establish valuation
• Results in 5 separate 20+ page agreements
• Usually takes 3-4 weeks minimum to complete and is
usually most expensive approach
• Best utilized for larger VC deals where larger proceeds
support higher cost
79
Equity – Series A Preferred Stock (cont.)
Terms of Series A Preferred Stock
• Economic terms:
– Liquidation Preference
– Dividends
– Anti-dilution protection
– Redemption
– Founder vesting
• Governance terms:
– Board composition
– Protective provisions
– Liquidity constraints
ROFR
Tag along
Drag along
80
Equity – Series A Preferred Stock (cont.)
Terms of Series A Preferred Stock (cont.)
• Others:
– Registration rights – Preemptive rights – Information rights
81
Equity – Series “Seed” Preferred Stock
• “Light” version of Series A Preferred
• Terms typically more founder friendly
• “Punt” on various terms until Series A Preferred
• Need to set valuation
• Quicker and less expensive than full Series A
Preferred, but still can be time consuming and
relatively expensive
82
Debt – Bank Debt
• Often requires personal guarantees
• Financial covenants
• Secured by cash flows and accounts receivable
• NOT typically an option for Start-ups!
83
Debt – Convertible Bridge Note
• Easy to do, very straightforward
– No need to set valuation today
– Limited or no governance rights
– Minimal terms to negotiate
Maturity
Interest rate
Discount to next round
– Can be made more complicated
Optional conversion at maturity
Caps on conversion valuation
Change of control acceleration
84
Debt – Convertible Bridge Note (cont.)
• Works best if subsequent financing is expected
(avoids “bridge to nowhere”)
• Short and sweet documentation
• Acceptable to a wide range of investors
• Now the predominant way to structure early stage
investments
85
TALES FROM THE TRENCHES
86
NETWORKING LUNCH
87
VALUATION & TERM SHEETS
88
Financing: Principles of Valuation
• Valuation: how much the company is “worth”
– Pre-money valuation
– Post-money valuation
• Valuation is the #1 issue in the negotiation between
the founder and the investor
• Valuation influenced by market conditions and
competition for the deal, amongst other factors
89
Valuation
• Valuation is expressed in terms of pre-money and post-
money
• Pre-Money is the valuation of the company before VC’s
invest
– Technically the Number of Shares Outstanding On a Fully
Diluted Basis Multiplied by the Proposed Price = The
Proposed Pre-Money Valuation
• Post-Money is the valuation after investment
– Pre-money + VC Investment= Post-money OR
– The Number of Shares Outstanding After the Close On a
Fully Diluted Basis Multiplied by the Price Per Share Paid
90
Valuation (cont.)
• Valuation – Percentage of equity interest
– “We’re willing to put $2M in at a $3M pre-money valuation”
– “We need to have 40% of the company if we are going to
invest $2M”
– When VC’s say they want a 40% stake in the Company for
$2M then the pre-money is $3M and post-money is $5M
• Factors that influence pre-money valuation:
– Leverage and the fundraising environment
– IP and milestones met (e.g., studies/trials/data)
– Size of market opportunity
– Experience of team
– Terms of transaction
• As much “art” as “science”
91
Valuation (cont.)
• Post-financing capitalization is viewed on a “fully-
diluted” basis
– Narrow-based formula – issued options
– Broad-based formula – includes option reserves
• Valuations are market driven and depend in large
part on the level of competition for the deal
• Valuations are sector specific
92
The Employee Option Pool
• The reserve amount is typically based on
anticipated headcount growth
• This time horizon is usually associated with the time
the financing dollars last
• The reserve amount is usually assessed and
replenished with each financing
93
Start-up Company Valuation Model
Example – Incorporation
• Founders A and B each purchase 1,750,000 shares of
common stock at a purchase price of $0.001 per share
Person # Shares % of Shares Value
A 1,750,000 50% $1,750
B 1,750,000 50% $1,750
Total 3,500,000 100% $3,500
94
Start-up Company Valuation Model
Example – Establishment of Option Plan
• In order to attract employees, the company establishes
an option plan and reserves 500,000 shares for issuance
under the plan
Person # Shares % of Shares Value
A 1,750,000 43.75% $1,750
B 1,750,000 43.75% $1,750
Option plan 500,000 12.5% $500
Total 4,000,000 100% $4,000
95
Start-up Company Valuation Model
Example – Initial Financing Round
• The company completes a $1,000,000 seed capital financing
round of Series Seed Preferred Stock at a purchase price of $1.00
per share, representing a $4,000,000 pre-money valuation.
Person # Shares % of Shares Value
A 1,750,000 35% $1,750,000
B 1,750,000 35% $1,750,000
Option plan 500,000 10% $500,000
Series Seed 1,000,000 20% $1,000,000
Total 5,000,000 100% $5,000,000
96
Start-up Company Valuation Model
Example – Series A Financing Round
• The company completes a $5,000,000 Series A financing at a
$15,000,000 pre-money valuation, at a purchase price of
$2.67 per share. The option pool is set at 15% post financing.
Person # Shares % of Shares Value
A 1,750,000 23.33% $4,666,667
B 1,750,000 23.33% $4,666,667
Option plan 1,125,000 15% $3,000,000
Series Seed 1,000,000 13.33% $2,666,667
Series A 1,875,000 25% $5,000,000
Total 7,500,000 100% $20,000,000
97
Preferred Stock – Term Sheet
• Preferred stock
• Valuation/option pool
• Liquidation preference
• Dividends
• Conversion features
• Antidilution protection (stock
splits, price-based)
• Voting rights
• Board composition
• Redemption
• Registration rights
• ROFR/Co-sale
• Preemptive rights
• Pay to play
• Founder/employee vesting
• Non-competes
• Exclusivity
• Expenses
• Confidentiality
98
Two Class Stock Structure
• Preferred and common stock
• Common stock is generally used for compensatory purposes (i.e., as
a form of payment to employees, board members, consultants,
advisors and other service providers) and issued to founders at
incorporation
• Preferred stock is generally used for investment purposes and has
many more rights, preferences and privileges than common stock
• Common stock is typically “priced” at a lower price than preferred
stock (i.e., for option granting purposes)
99
Liquidation Preference
• Investors get a “Liquidation Preference” in the event of a liquidity
event of the company
• “Liquidity events” include M&A transactions
• A typical liquidation preference would provide the investors their
money back before any other stockholders receive any proceeds
• A “participating” liquidation preference entitles investors to their
money back, plus the right to participate in the remaining amounts
• Caps are often negotiated
100
Liquidation Preference
Example of Fully and Non Participating Preferreds
(assumes $30m sale price and $6m invested)
Shares % o/s
Liquidation
preference
Payment of
remainder
Total
proceeds
Total
proceeds
with no
participation
Seed 1,000,000 13.33% $1,000,000 $3,200,000 $4,200,000 $4,000,000
A 1,875,000 25.00% $5,000,000 $6,000,000 $11,000,000 $7,500,000
Common
(founders) 3,500,000 46.66% N/A $11,200,000 $11,200,000 $14,000,000
Option
pool 1,125,000 15.00% N/A $3,600,000 $3,600,000 $4,500,000
Total 7,500,000 100.00% $6,000,000 $24,000,000 $24,000,000 $30,000,000
101
Dividends
• Accruing/non-accruing
• Compounding/non-compounding
• Payable on specified dates/payable “if, as and
when” declared
• Participating/non-participating
102
Conversion
• Preferred stock convertible into common stock at
option of holder, initially on one for one basis
– Automatically convert upon an IPO
Typically size of deal and share price must exceed
certain levels
– Automatically convert upon the vote of the particular
series
103
Antidilution Protection
• Conversion rate adjusts on certain events – Proportionate in the event of stock splits
– Price based antidilution upon a “down round” financing Weighted average protection: Conversion price is adjusted
based on a formula that considers the number of new
shares being issued compared to the shares outstanding
and the price at which the new shares are issued
Full ratchet protection: Conversion price is adjusted so that
the price per share is reset to the price per share in the new
financing, regardless of the number of shares issued and the
price at which they are issued.
– Provide for appropriate carveouts to antidilution protection
(i.e., for option issuances, strategic warrants, etc.)
104
Antidilution Protection
• Conversion rate adjusts on certain events – Proportionate in the event of stock splits
– Price based antidilution upon a “down round” financing Weighted average protection: Conversion price is adjusted
based on a formula that considers the number of new
shares being issued compared to the shares outstanding
and the price at which the new shares are issued
Full ratchet protection: Conversion price is adjusted so that
the price per share is reset to the price per share in the new
financing, regardless of the number of shares issued and the
price at which they are issued.
– Provide for appropriate carveouts to antidilution protection
(i.e., for option issuances, strategic warrants, etc.)
105
Board Composition/Voting Rights
• Companies are controlled by the board of directors
– Control over the board means control over the company
– Typical board composition post Series A investment is two
founders, two Series A investor representatives and one
industry expert/independent
• Even if board approves, “protective provisions” require
preferred holders to approve certain events, including:
– Change of control transactions
– Amendments to charter/bylaws
– Hiring/firing senior management
– Issuing senior securities
– Increasing size of the option pool
– Incurring debt
106
Other Terms
• Redemption
• Registration rights
• ROFR/Co-Sale
• Preemptive rights
Last but not least, legal expenses!
107
WSGR Term Sheet Generator tool
• This tool will generate a venture financing term sheet based
on your responses to an online questionnaire. It also has an
informational component, with basic tutorials and annotations
on financing terms. This term sheet generator is a modified
version of a tool that we use internally, which comprises one
part of a suite of document automation tools that we use to
generate start-up and venture-financing-related documents.
• Because it has been designed as a generic tool that takes into
account a number of options, this version of the term sheet
generator is fairly expansive and includes significantly more
detail than would likely be found in a customized application.
108
Instructions for logging into the WSGR Term
Sheet Generator
1. Go to: www.wsgr.com
2. Click on “Practices” then select “Entrepreneurial Services”
from the list
3. Click on “WSGR Term Sheet Generator” (In the far left
hand column under “Related Information”)
4. Click on “Launch” button
109
LIQUIDITY & EXITS
110
Corporate Governance
• The Role of the Board of Directors
• Composition of your Board of Directors
• Good corporate governance, and why it matters for
the private company
• Working effectively with your Board of Directors
111
The Role of the Board of Directors
• Generally, the role of the Board of Directors is to
evaluate and approve the company’s business strategy;
oversee and compensate senior executives; and ensure
accountability of the corporation
• Under Delaware law, – the role of Board is to “direct or manage the business and
affairs of the corporation”
– the Board has broad powers to exercise its authority,
including to amend bylaws, approve stock and option
issuances, hire and fire the CEO and other executive
officers, approve acquisitions, and approve (with the
stockholders) the sale of the Company
112
The Composition of the Board of Directors
• State law and the company’s Charter documents specify the
number of directors
• Keep it small – The Board of Directors is not the same as a Board of Advisors
– Boards of Directors have a lot of power, and require significant
commitment of time and effort
– Difficult to remove Board members (removal for cause; classified
Boards)
• Who? – CEO, other Common Stock representatives
– Venture capital and other investor representatives
– Independent Board members, with breadth and depth of
experiences - technical, sales, marketing, finance, and industry
knowledge
• The balance of power – on the Board and with the stockholders
113
The Board’s Fiduciary Duties &
Obligations Under Law • Duty of Care
• Duty of Loyalty
• Court standards – The Business Judgment Rule
– Entire Fairness Standard
• Special situations – Interested director transactions; conflicts of interest
– Sale of the company
114
Good Corporate Governance & Why it
Matters to the Private Company • What is Corporate Governance?
– The rules, processes, customs, policies, laws, and
institutions affecting the way a company is directed,
administered and controlled, and interacts with its
stakeholders
– Sources State corporate law and state courts
Federal law (e.g., Congress) and agencies (e.g. SEC)
Stock exchanges (NYSE and Nasdaq listing standards)
Other
– Shareholder organizations (e.g., RiskMetrics/ISS)
– Plaintiffs’ bar
115
Good Corporate Governance & Why it
Matters to the Private Company (cont.)
• Why it matters to the private company – Well-thought out process and structure help establish trust
and credibility among constituents
– Better satisfies the Board’s key oversight responsibilities
– Better prepares the company for an initial public offering or
other liquidity event NYSE and Nasdaq listing standards require independent,
qualified Board committees and other corporate governance
measures
Sarbanes-Oxley controls; risk management
– Attracts qualified Board members (director candidates
expect good corporate governance)
– Demonstrates to prospective D&O insurance carriers that
the company is an appropriate underwriting risk
116
Working Effectively with your Board
• Structure and process (have an agenda, schedule regular Board
meetings with advance notice, and ensure timely delivery of
Board materials)
• No surprises at a Board meeting
• Recognizing and addressing conflicts of interest (disclosure and
process)
• Dealing effectively with differences in opinion
• Being sensitive to liability concerns
• Record keeping best practices (Board packages; minutes)
• Consider elective corporate governance practices – Committee structure (Audit, Compensation, other)
– Adding independent directors
– Executive Board sessions (without management)
117
Paths to Liquidity
• The traditional paths – IPO – M&A
• Alternative paths – Achieve profitability and pay dividends
May be accelerated with the right corporate partnerships Not a typical path for VC investors
– Secondary market for private company shares Generally not a strong market for companies that don’t show
good prospects of obtaining liquidity in another way Several VC financing terms designed to make this difficult to
tap (rights of first refusal/co-sale rights)
• Liquidity events are not always “exits”
118
Benefits of an IPO
• Liquidity for investors/employees – Post-lockup and subject to insider trading compliance
• Opportunity for investors to personalize when they sell
• Access to capital
• Acquisition currency
• Prestige and perceived stability – As long as the stock price holds up
• Employee compensation alternatives
119
Drawbacks of an IPO
• Loss of confidentiality
• Potential loss of control – Stockholder activism
• Increased compliance burdens
• Increased legal exposure
• Tyranny of quarterly results
• Execution challenges (market choppiness)
• Cost of capital – Management time and offering expense
• Risk of stock price decline
120
What It Takes to Go Public
• IPO prospects are at the mercy of the market – “Windows” open and close quickly
– What is hot and the criteria for a successful offering move with
the market’s tides
– Top companies can sometimes defy the market’s laws of gravity
• Factors that generally excite potential underwriters are: – Revenue scale (typically at least $50M annually, often much
higher)
– Compelling growth prospects (“20% is the new 30%”)
– Profitability (1 or 2 quarters with momentum desirable)
– Sustainability and visibility
– Unique/disruptive solution and/or ties to “hot” investment themes
– Scalability to achieve growth potential
– Solid management team
– Financial controls, reporting and Board/governance infrastructure
121
Benefits of a Sale
• Liquidity for investors/employees – Typically obtained more quickly than with an IPO
• Lowers standalone execution risk – More market power/presence/capital
– Turbulent quarterly results can be made less significant when combined
with a larger enterprise
• Not all companies have the growth and scalability to go
public
• Maintain confidentiality (vis a vis public) to a greater degree
• Lower required investment in administration
• Synergies may favorably impact valuation
• Liquidation preference for investors
122
Risks and Costs
• Disruption of business
• Confidentiality issues
• Substantial costs and negotiation time
• Loss of control
• Potential to be “left at the altar”
• Unless for cash, acquiror’s stock performance risks
• Liquidation preferences and carve-outs
• Escrows, indemnities and earn-outs
• Failure to integrate and execute successfully
123
Timing Factors
• Competitive threats
• Market consolidation means you could be left without dance partner
• Solid performance (ideally)
• Potential to step up a level in combined company
• Non-receptive IPO market
124
Selected M&A Issues
• The Board Process and Role
• Shopping the Company
• Carve-out Plans
• Change of Control Acceleration
• Re-incentivizing Continuing Key Management and
Employees
• Non-competes and Change in Control Agreements
• Earnouts
• Indemnification and Escrow Provisions
125
Earn-outs
• Used to bridge “valuation gap”
• Structural considerations – Objective vs. subjective earn-out milestones
– R&D milestones
– Commercial introduction milestones
– Revenue metrics (other financial metrics more
difficult)
– All or none vs. proportional or quasi-proportional
– “Last man standing” issues
– Duration and staging of earn-outs
– “Freedom to operate” conflicts
126
Escrow Purpose, Size and Duration
• Security for indemnity of stockholders for breaches of representations, warranties and covenants
• Typical size is 10-20% of purchase price – Special escrows for known specific liabilities or
contingencies
• Typically duration is one year to two years – Are there commercial or product development events
that suggest longer or shorter escrow/indemnity periods?
– Are there identifiable contingent liabilities where special escrow/indemnity terms should be applied?
– Indemnity for certain matters, including fraud, typically of longer duration
127
Escrow as a Cap on Liability Exposure
• Typically escrow is exclusive remedy other than fraud
• Other considerations: – Is escrow too small to be the only remedy in light of
risk profile of target company? – Indemnity beyond escrow for additional percentage
or all of deal price? – Should asset deal structure be considered in light of
liability risks of target?
• Other potential exceptions to exclusivity: – Tax – Capitalization – Environmental – Intellectual Property
128
Sale Strategy Issues
• Valuation is generally determined by 3 things: – Ability to pay (buyer’s balance sheet, tolerance for dilution, etc…)
– Willingness to pay (strategic importance, limited alternatives, fit)
– Need to pay (competition, including IPO)
• Be careful about over-optimizing: – It takes luck to perfectly time the market
– Negotiators who overplay their leverage can miss good deals
• Technology companies tend to be bought not sold
• Know your investors - different constituencies may have
different outcome priorities – Liquidation preferences
– Value expectations and basis
– Views of market trends
– Management’s desire to keep or divest control
129
Sale Tactical Issues
• Shopping the company – Market checks, broad and narrow auctions
– Keeping confidentiality, managing leaks
– Role of a banker
• Designing the Board process – Board duties and role
• Indemnification and escrow provisions – Caps and baskets
– Time periods
– Myriad process points to negotiate
• Earn-outs – Milestones
– “Freedom to operate” conflicts
130
Planning for Liquidity
• Discuss liquidity strategy regularly with key investors – Seek alignment (or at least understanding) on priorities and timing
expectations
• Assess preferred stock terms in light of implications for liquidity alternatives
– Carve out plans and recaps
• Develop the infrastructure required to achieve liquidity objectives – Managing toward a sale can be different than managing toward an IPO – Consider the doors opened and closed by partnerships and exclusivities – Consider capabilities and risks in light of how the company would be
marketed
• Pay attention to the market – Watch for consolidation trends – they can accelerate quickly
Market consolidation can leave some players without a dance partner
– Build relationships around the industry; never eat lunch alone
• Keep your nose clean – Auditor relationships – Legal best practices – Risk management
131
TALES FROM THE TRENCHES
132